First US Warnings On Drug Claims By Delta-8 THC Supplements Also Describe Safety Concerns

Announcement and warnings, in addition to noting firms’ violative drug and disease claims, explain differences between delta-8 THC and other hemp-derived cannabinoids intended for de-scheduling as controlled substances in 2018 farm bill.

FDLI August 2021 presentation

Warning letters to five US firms about unlawful claims for products labeled as containing delta-8 tetrahydrocannabinol were the Food and Drug Administration’s firsts about the ingredient but almost certainly won’t be the last and just as surely were late in coming.

More from Cannabis/CBD

More from Ingredients & Safety